Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 7175-7179

  Weingart, Christine L ^a,d   Keitel, Wendy A ^b   Edwards, Kathryn M ^c   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; COMPLEMENT; PERTUSSIS VACCINE;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; NEUTROPHIL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVACCINATION; VACCINATION;

ADENYLATE CYCLASE; ADHESINS, BACTERIAL; ADULT; BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT SYSTEM PROTEINS; HEMAGGLUTININS; HUMANS; NEUTROPHILS; PERTUSSIS VACCINE; PHAGOCYTOSIS; VACCINATION; VACCINES, ACELLULAR; VIRULENCE FACTORS, BORDETELLA;

EID: 0034440543     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.7175-7179.2000     Document Type: Article

References (27)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet i:955-960.
2. Ausiello, C. M., F. Urbani, A. la Sala, R. Lande, and A. Cassone. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
3. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. G. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
4. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
5. Fernandez, R. C., and A. A. Weiss. 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:4727-4738.
6. Fernandez, R. C., and A. A. Weiss. 1998. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 163:57-63.
7. Goodwin, M. S. M., and A. A. Weiss. 1990. Adenylate cyclase toxin is critical for bacterial colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect. Immun. 58:3445-3447.
8. Hewlett, E. L. 1997. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. 16(Suppl. 4):S78-S84.
9. Jagels, M. A., P. J. Daffern, B. L. Zuraw, and T. E. Hugli. 1999. Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 21:418-427.
10. Keitel, W. A., L. R. Muenz, M. D. Decker, J. A. Englund, C. M. Mink, D. A. Blumberg, and K. M. Edwards. 1999. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J. Infect. Dis. 180:397-403.
11. Khelef, N., C. M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900.
12. Lenz, D. H., C. L. Weingart, and A. A. Weiss. 2000. Phagocytosed Bordetella pertussis fail to survive in human neutrophils. Infect. Immun. 68:956-959.
13. McGuirk, P., and K. H. G. Mills. 2000. A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines. Infect. Immun. 68: 1383-1390.
14. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
15. Parton, R. 1999. Review of the biology of Bordetella pertussis. Biologicals 27: 71-76.
16. Persson, C. G. A., I. Erjefalt, U. Alkner, C. Baumgarten, L. Grief, B. Gustafsson, A. Luts, U. Pipkorn, F. Sundler, C. Svensson, and P. Wollmer. 1991. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21:17-24.
17. Plotkin, S. A., and M. Cadoz. 1997. The acellular pertussis vaccine trials: an interpretation. Pediatr. Infect. Dis. J. 16:508-517.
18. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, and K. H. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
19. Ryan, M., G. Murphy, E. Ryan, L. Nilsson, F. Shackley, L. Gothefors, K. Oymar, E. Miller, J. Storsaeter, and K. H. Mills. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
20. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
21. Strzelecka, A., K. Kwiatkowska, and A. Sobota. 1997. Tyrosine phosphorylation and Fcγ receptor-mediated phagocytosis. FEBS Lett. 400:11-14.
22. Weingart, C. L., G. Broitman-Maduro, G. Dean, S. Newman, M. Peppler, and A. A. Weiss. 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67:4264-4267.
23. Weingart, C. L., and A. A. Weiss. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68:1735-1739.
24. Weingart, C. L., P. S. Mobberley, E. L. Hewlett, M. C. Gray, and A. A. Weiss. 2000. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 68:7152-7155.
25. Weiss, A. A., and M. S. Goodwin. 1989. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun. 57:3757-3764.
26. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis. 150:219-222.
27. Weiss, A. A., P. S. Mobberley, R. C. Fernandez, and C. A. Mink. 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1424-1431.